Archives for July 13, 2015

← 2015

CiMaas selects PharmaCell as CMO for early efforts with cell therapies

By Zachary Brennan

CiMaas BV, a company developing cellular immunotherapies to treat cancer, has selected CMO (contract manufacturing organization) PharmaCell, to help in the clinical development and manufacturing of CiMaas’ ATMPs (Advanced Therapy Medicinal Products).